EVA Tx is the new name for EpiVax Therapeutics (EVT) resulting from the establishment of a new majority shareholder, @GAIA Vaccine Foundation. EVA Therapeutics aims to become a global leader in computational vaccine design for LMIC-focused diseases, accelerating solutions for neglected pathogens and supporting equitable vaccine access worldwide. Over time, EVA (an acronym for Equitable Vaccine Access) will build a pipeline of affordable, scalable vaccine candidates ready for downstream partners to manufacture and distribute in LMIC markets.
| Website | http://www.eva-therapeutics.com |
| Employees | 4 (3 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research |
Looking for a particular EVA Therapeutics employee's phone or email?
EVA Therapeutics Questions
Annie de Groot is the Founder and President of EVA Therapeutics.
3 people are employed at EVA Therapeutics.
EVA Therapeutics is based in Providence, Rhode Island.
Top EVA Therapeutics Employees
-
Annie de Groot
Founder and President at EVA Therapeutics
Providence, RI, US23 -
Jeffrey Safrit
CEO at EVA Therapeutics
Los Angeles, CA, US15+ -
Despina Durand
Finance Manager at EVA Therapeutics
Providence, RI, US21
